New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test ...

New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

Researchers studied synthetic lethality pathway using Promega NanoBRET(R) TE technology -- Study is the first to characterize uncompetitive binding directly in live cells, illuminating a mechanistic ...

What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the ...

Ovarian cancer tends to be resistant to hormone therapy, even when it should theoretically respond. Wistar Institute ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

In the field of cancer research, bioinformatics plays a pivotal role in dissecting the intricate molecular interactions that dictate cancer development and ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing at a CAGR of 6.4% during 2025–2035.

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has ...

In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.

UCLA’s CAR-NKT therapy overcomes solid-tumor barriers, eliminating primary and metastatic pancreatic cancer in advanced ...